Endo International PLC (NASDAQ:ENDP) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 20,084,394 shares, a decline of 11.0% from the June 15th total of 22,575,855 shares. Based on an average daily trading volume, of 5,194,844 shares, the short-interest ratio is presently 3.9 days. Approximately 10.1% of the company’s shares are sold short.
Institutional investors have recently modified their holdings of the stock. OppenheimerFunds Inc. boosted its position in shares of Endo International PLC by 182.9% in the first quarter. OppenheimerFunds Inc. now owns 2,873,153 shares of the company’s stock valued at $32,065,000 after buying an additional 1,857,678 shares during the period. Bank of New York Mellon Corp boosted its position in shares of Endo International PLC by 38.7% in the first quarter. Bank of New York Mellon Corp now owns 2,271,111 shares of the company’s stock valued at $25,345,000 after buying an additional 633,904 shares during the period. First Quadrant L P CA bought a new position in shares of Endo International PLC during the first quarter valued at about $24,556,000. Norges Bank bought a new position in shares of Endo International PLC during the fourth quarter valued at about $26,929,000. Finally, Schneider Capital Management Corp boosted its position in shares of Endo International PLC by 14.9% in the first quarter. Schneider Capital Management Corp now owns 642,311 shares of the company’s stock valued at $7,168,000 after buying an additional 83,100 shares during the period. 93.15% of the stock is owned by institutional investors and hedge funds.
Endo International PLC (ENDP) opened at 11.03 on Friday. Endo International PLC has a one year low of $9.70 and a one year high of $24.93. The stock’s 50 day moving average price is $11.48 and its 200-day moving average price is $11.84. The company’s market capitalization is $2.46 billion.
Endo International PLC (NASDAQ:ENDP) last issued its quarterly earnings data on Tuesday, May 9th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.10 by $0.13. The business had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Endo International PLC had a positive return on equity of 25.32% and a negative net margin of 82.93%. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.08 EPS. Equities analysts forecast that Endo International PLC will post $3.54 EPS for the current year.
Several research firms have recently issued reports on ENDP. Canaccord Genuity set a $12.00 target price on Endo International PLC and gave the company a “hold” rating in a research note on Thursday, June 8th. Oppenheimer Holdings, Inc. reissued a “hold” rating on shares of Endo International PLC in a research note on Thursday, June 8th. Stifel Nicolaus cut Endo International PLC from a “buy” rating to a “hold” rating and reduced their target price for the company from $22.00 to $15.00 in a research note on Friday, June 9th. ValuEngine cut Endo International PLC from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Finally, Mizuho reaffirmed a “buy” rating and issued a $19.00 price target (up from $18.00) on shares of Endo International PLC in a research note on Thursday, May 25th. Two analysts have rated the stock with a sell rating, sixteen have issued a hold rating and six have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $17.33.
COPYRIGHT VIOLATION NOTICE: “Endo International PLC (NASDAQ:ENDP) Sees Significant Drop in Short Interest” was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://stocknewstimes.com/2017/07/30/endo-international-plc-nasdaqendp-sees-large-decrease-in-short-interest-updated.html.
About Endo International PLC
Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.
Receive News & Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related companies with MarketBeat.com's FREE daily email newsletter.
